Form 4: Paychex Chairman Martin Mucci Receives Equity Awards
Insider Transaction Report
Paychex Inc. Chairman Martin Mucci was granted 194 restricted stock units and 790 stock options, aligning his interests with long-term shareholder value.
Summary
- Martin Mucci, Chairman and Director of Paychex Inc. (PAYX), reported changes in his beneficial ownership.
- On July 15, 2025, Mucci was awarded 194 shares of Common Stock as Restricted Stock Units (RSUs) at a price of $0, subject to vesting pursuant to the Amended and Restated 2002 Stock Incentive Plan.
- Following this RSU award, Mucci directly beneficially owns 425,469.3318 shares of Common Stock.
- On the same date, Mucci was granted 790 stock options with an exercise price of $140.68 per share. These options become exercisable on July 15, 2026, and expire on July 14, 2035.
- Mucci also holds several other stock options with various exercise prices and expiration dates, including 214,482 options at $57.24, 179,191 options at $69.54, 195,228 options at $85.46, 195,428 options at $73.53, 108,086 options at $112.67, 3,299 options at $109.19, 3,985 options at $120.86, and 3,949 options at $121.63.
Sentiment
Score: 6
Explanation: The filing is largely neutral as it reports a routine insider transaction (equity grant). It's slightly positive as it aligns management's interests with shareholders through equity compensation, but it doesn't contain information about company performance or strategic developments.
Positives
- The grant of restricted stock units and stock options to Chairman Martin Mucci aligns management's incentives with long-term shareholder value.
- The awards are part of a standard stock incentive plan, indicating routine compensation practices.
Negatives
- No specific negative information is present in this Form 4 filing.
Risks
- The value of the equity awards is subject to the future performance of Paychex Inc.'s stock price.
- Vesting conditions for the restricted stock units mean the shares are not immediately owned outright and could be forfeited if conditions are not met.
Future Outlook
The document primarily reports past and scheduled future equity grants and does not provide a general future outlook for the company's business operations or financial performance. The future vesting of RSUs and exercisability of options are tied to future dates.
Industry Context
This Form 4 filing reflects a routine equity compensation event for a senior executive at a publicly traded company in the human capital management and payroll services industry. Such grants are common practice to incentivize and retain key management personnel, aligning their interests with long-term company performance and shareholder value.
Comparison to Industry Standards
- Equity grants, including restricted stock units and stock options, are standard components of executive compensation packages across various industries, including the financial services and human capital management sectors.
- The specific number of shares and options granted to Martin Mucci would typically be benchmarked against compensation practices for executives of similar roles and company sizes within the industry, such as those at ADP, Ceridian HCM Holding Inc. (CDAY), or Workday, Inc. (WDAY). However, this document does not provide the necessary context for a detailed comparative analysis of compensation levels.
Stakeholder Impact
- Shareholders: The equity awards align the Chairman's interests with shareholders, potentially fostering long-term value creation.
- Employees: No direct impact on general employees is indicated.
- Customers: No direct impact on customers is indicated.
- Suppliers: No direct impact on suppliers is indicated.
- Creditors: No direct impact on creditors is indicated.
Next Steps
- The newly granted restricted stock units are subject to vesting.
- The newly granted stock options will become exercisable on July 15, 2026.
Key Dates
| Date | Description |
|---|---|
| 07/12/2018 | Date exercisable for 214,482 stock options with an exercise price of $57.24. |
| 07/11/2019 | Date exercisable for 179,191 stock options with an exercise price of $69.54. |
| 07/10/2020 | Date exercisable for 195,228 stock options with an exercise price of $85.46. |
| 07/15/2021 | Date exercisable for 195,428 stock options with an exercise price of $73.53. |
| 07/15/2022 | Date exercisable for 108,086 stock options with an exercise price of $112.67. |
| 10/15/2023 | Date exercisable for 3,299 stock options with an exercise price of $109.19. |
| 07/15/2024 | Date exercisable for 3,985 stock options with an exercise price of $120.86. |
| 07/15/2025 | Transaction date for the acquisition of 194 restricted stock units and 790 stock options; also the date exercisable for 3,949 stock options with an exercise price of $121.63. |
| 07/17/2025 | Filing date of the SEC Form 4. |
| 07/15/2026 | Date exercisable for 790 newly granted stock options with an exercise price of $140.68. |
| 07/11/2027 | Expiration date for 214,482 stock options with an exercise price of $57.24. |
| 07/10/2028 | Expiration date for 179,191 stock options with an exercise price of $69.54. |
| 07/09/2029 | Expiration date for 195,228 stock options with an exercise price of $85.46. |
| 07/14/2030 | Expiration date for 195,428 stock options with an exercise price of $73.53. |
| 07/14/2031 | Expiration date for 108,086 stock options with an exercise price of $112.67. |
| 10/14/2032 | Expiration date for 3,299 stock options with an exercise price of $109.19. |
| 07/14/2033 | Expiration date for 3,985 stock options with an exercise price of $120.86. |
| 07/14/2034 | Expiration date for 3,949 stock options with an exercise price of $121.63. |
| 07/14/2035 | Expiration date for 790 newly granted stock options with an exercise price of $140.68. |
Keywords
Paychex, PAYX, SEC Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, RSU, Stock Options, Equity Compensation, Martin Mucci, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.